Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
about
Critical analysis of compositions and protective efficacies of oral killed cholera vaccinesModeling cholera outbreaksStrategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti OutbreakMucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motilityVaccination strategies for epidemic cholera in Haiti with implications for the developing world.Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.Validation of a volunteer model of cholera with frozen bacteria as the challengeMeeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and careKilled oral cholera vaccines: history, development and implementation challengesExperimental non-O group 1 Vibrio cholerae gastroenteritis in humans.Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau.Vibrio cholerae: lessons for mucosal vaccine design.Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.Development of a rapid and specific colony-lift immunoassay for detection and enumeration of Campylobacter jejuni, C. coli, and C. lariFactors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxinImmunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmissionThe Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routesSynthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits.Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adultsMemory T-cell responses to Vibrio cholerae O1 infection.The utility of human challenge studies in vaccine development: lessons learned from cholera.Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen.Protection of rat intestine against cholera toxin challenge by monoclonal anti-idiotypic antibody immunization via enteral and parenteral routes.A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.
P2860
Q26823170-134C7057-5FE8-4AAB-964D-4FF9904FD913Q27006979-51E5C072-D343-4B23-95CB-0FB8A5DD664DQ28552894-3C583AD8-3A2F-4F7E-9010-0C15C6D260A2Q30496874-A8723BD4-032F-4872-AFB7-F34966FE851BQ30499938-28AB4E7F-533F-47BA-A2DE-D24A94F20D21Q33263833-D1550385-033B-45FA-8472-3E4C238215A7Q33753583-7C28F981-4C61-4ADA-AB7D-8691455E568AQ33927450-1C7CC9A5-0CF2-453F-884F-F90B85C4B2EBQ34087755-31E25DA3-71AA-434F-A981-C8BDF270AF3CQ34244632-554DD6D6-BDBB-4754-A698-5F9C23442144Q34474623-BC13C800-1216-42EE-89C8-FDBA486F08E9Q34562952-C58FF77F-D54E-423A-B571-44A7A5F18CAFQ34633653-65ED005C-8B2B-4BFA-9EC3-73F463EED538Q35090620-45FE2BDD-2A8A-41AB-8D88-05305230DE54Q35228033-20119401-EF60-4B0E-8706-491F7D4314F4Q35460365-FE0DE964-7B74-4B63-A3D4-1238FDE4D10EQ35546011-5312D91E-AE6B-48B0-9514-0B5FCC0F1CB8Q35655408-1E3919AF-3A73-47C5-AA9A-CA97BEA73B23Q35669021-CEEEE61B-F88C-4F4F-84D3-4F1FF62385FEQ35754539-C32010D4-019D-43BA-A71D-F0CECFA01953Q36760192-0918440F-A104-4442-8374-3264E7FEB1DBQ36949262-8DA306E0-6D1A-43E0-AF2F-438FC6808033Q36992532-D182FD2D-892F-4BDF-9FF5-143E747E6CAEQ36992602-F89BE0CB-7DBE-4ED0-A5A4-2AD4DDE3799EQ36992817-02C07FA3-0444-44C2-953B-799CCCFC9EC1Q37004503-20B6F771-D0B8-4833-8D2C-0FAEDDFF43D0Q37410387-64FDE192-B6A3-4922-B427-2D828F707DABQ37523806-DBA0D3FC-44C0-4104-8BE0-1D5D2D66F0EBQ38680503-24DFB3B6-2BEF-42BF-AFE6-AE3E3F9776ADQ39250333-25BCE52A-4AB1-4B59-A4CB-9494F8621A9DQ39250338-4A9D4BE8-AD74-4A27-BFCF-035BB3D54779Q39822285-08EFA409-0EE7-4379-92FC-2DB183A5922EQ39822312-E5C3F079-71BD-4AA0-8A54-81789D3979A7Q40151000-1C2C3703-1657-4000-BB35-F480CEB4E568Q40155636-44F6B519-DCDC-46D2-9CB0-F90D0969CB10Q41417451-C7922875-CE91-4D9F-8093-6AF62263108D
P2860
Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1987
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protective efficacy in humans ...... he B subunit of cholera toxin.
@en
Protective efficacy in humans ...... he B subunit of cholera toxin.
@nl
type
label
Protective efficacy in humans ...... he B subunit of cholera toxin.
@en
Protective efficacy in humans ...... he B subunit of cholera toxin.
@nl
prefLabel
Protective efficacy in humans ...... he B subunit of cholera toxin.
@en
Protective efficacy in humans ...... he B subunit of cholera toxin.
@nl
P2093
P2860
P50
P1476
Protective efficacy in humans ...... he B subunit of cholera toxin.
@en
P2093
M L Clements
M M Levine
P2860
P304
P407
P577
1987-05-01T00:00:00Z